The effects of Luo-Bu-Fu-Ke-Bi-RI pill
NCT ID NCT05846698
First seen Sep 09, 2026 ยท Last updated Sep 09, 2026
Summary
To investigate the effect of LBFKBRP on climacteric syndrome in women and explore its therapeutic mechanism.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
300 people
The number who actually took part.
- Started
-
Sep 2021
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
female
- Ages
-
41 to 60 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Clinical diagnosis of climacteric syndrome
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Climacteric syndrome are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.